Entry: €17.00- €17.20
Stop: €15.50 (can consider lower if longer term outlook)
Target: €20.50 & ultimately €23.00 yearly retest from February drop.
Gain: +19.48% & longer term target +33.72%
Note: among highest rated European insurers with solid and strong upside potential. Risk to upside thesis stem from claims due to Corona closures, lawsuits etc...